Cancer Vaccines Market Trends, Demand, Price, Analysis and Forecasts to 2022

According to Stratistics MRC, the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients, increasing ageing population and awareness of vaccines are fueling the market. However, less availability of vaccines and advanced treatments in underdeveloped regions may limit the market growth.

North America accounted for the largest share in the market followed by Asia Pacific. The favourable growth is attributed to supportive government and other organisations such as World health organisation and GAVI initiatives.

Browse full report with TOC@ https://marketreportscenter.com/reports/415514/cancer-vaccines-global-market-outlook-2016-2022

Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited-P.P. Enterprises, Juvaris Biotherapeutics, Merk&co, Prima BioMed Ltd, Cytos Biotechnology AG, Ubivac, duro BioTech, AstraZeneca plc., and MedImmune, LLC.

Disease Indication Covered:

Cervical cancer

Esophageal cancer

Liver cancer

Prostate cancer

Lung cancer

Breast cancer

Stomach cancer

Technologies Covered:

Inactivated Vaccines

Peptide/protein vaccines

Synthetic Vaccines

Toxoid Vaccines

Live Attenuated Vaccines

Recombinant Vector Vaccines

Antigen vaccines

Dendritic Cell Vaccines

Subunit Vaccines

Heat shock protein vaccines

DNA- and vector-based vaccines

Conjugate Vaccines

Anti-idiotype vaccines

Cancer stem cell vaccines

End Users Covered:

Adults

Paediatrics

Vaccine Types Covered:

Therapeutic Vaccines

Preventive Vaccines

What our report offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic recommendations for the new entrants

- Market forecasts for a minimum of 7...